CytRx Regains NASDAQ Compliance
Courtesy of Benzinga.
CytRx Corporation (Nasdaq: CYTR) today announced that it received written notification on May 31, 2012 from the NASDAQ Listing Qualifications Department that it has regained compliance with the minimum bid price requirement set forth in NASDAQ Listing Rule Section 5550(a)(2) for continued listing of its common stock on The NASDAQ Capital Market.
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
For more Benzinga, visit Benzinga Professional Service, Value Investor, and Stocks Under $5.
Do you know someone
who would benefit from this
information? We can send your friend a strictly
confidential, one-time email telling them about this
information. Your privacy and your friend's privacy is
your business... no spam! Click here
and tell a friend!

Twitter
LinkedIn
del.icio.us